Name:	akca_MaximumAmountOfPaymentsReceivablePerDrugOrProgramForRegulatoryMilestones
Namespace Prefix:	akca_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Milestone payments and royalties payable percentage.

No definition available.

Name:	akca_MilestonePaymentsAndRoyaltiesPayablePercentage
Namespace Prefix:	akca_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

Milestone payments and royalties retained percentage.

No definition available.

Name:	akca_MilestonePaymentsAndRoyaltiesRetainedPercentage
Namespace Prefix:	akca_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

Payment for sub-license royalty.

No definition available.

Name:	akca_PaymentForSubLicenseRoyalty
Namespace Prefix:	akca_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Period of time before collaboration partner pays royalties on net sales of product after first commercial sale in Brazil, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

No definition available.

Name:	akca_PeriodBeforeCollaborationPartnerPaysRoyaltiesOnNetSalesOfProductAfterFirstCommercialSaleInBrazil
Namespace Prefix:	akca_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

The number of separate performance obligations under the collaboration agreement.

No definition available.

Name:	akca_RevenueFromContractWithCustomerNumberOfSeparatePerformanceObligations
Namespace Prefix:	akca_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

The minimum amount of revenue recognized in Latin America by the collaboration partner before paying royalties.

No definition available.

Name:	akca_RevenueRecognizedByCollaborationPartnerInLatinAmericaBeforePayingRoyalties
Namespace Prefix:	akca_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

The amount of the upfront payment to be paid on the earlier of approval by the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) under the collaboration agreement.

No definition available.

Name:	akca_UpfrontPaymentToBePaidAfterApproval
Namespace Prefix:	akca_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Name:	us-gaap_ContractWithCustomerLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Cash received from licensees for license fees during the current period.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585

Name:	us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Name:	us-gaap_TypeOfArrangementAxis=akca_CollaborativeArrangementAndLicensingAgreementEnteredIntoInAugust2018WithPTCTherapeuticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_ConsolidatedEntitiesAxis=akca_AkceaTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_ProductOrServiceAxis=akca_TEGSEDIMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_OwnershipAxis=akca_IonisPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: